Nordoxepin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nordoxepin" in English language version.

refsWebsite

Global rank English rank

3^rd place

2^nd place

4^th place

11^th place

8^th place

3,823^rd place

2,387^th place

books.google.com

Williams DA (24 January 2012). "Antidepressant". In Lemke TL, Williams DA (eds.). Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. pp. 605–. ISBN 978-1-60913-345-0.
Dawkins K, Manji HK, Potter WZ (20 September 1994). "Pharmacodynamics of Antidepressants". In Cutler NR, Sramek JJ, Narang PK (eds.). Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology. John Wiley & Sons. pp. 160–. ISBN 978-0-471-95052-3.
Baumann P, Hiemke C (23 February 2012). "Central Nervous System Drugs". In Anzenbacher P, Zanger UM (eds.). Metabolism of Drugs and Other Xenobiotics. John Wiley & Sons. pp. 302–. ISBN 978-3-527-64632-6.
Nelson JG (2009). "Tricyclic and Tetracyclic Drugs". In Schatzberg AF, Nemeroff CB (eds.). The American Psychiatric Publishing Textbook of Psychopharmacology. American Psychiatric Pub. pp. 264–. ISBN 978-1-58562-309-9.

Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, et al. (August 2005). "Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets". Pharmacogenetics and Genomics. 15 (8): 579–587. doi:10.1097/01.fpc.0000167331.30905.9e. PMID 16007002. S2CID 41765748.
Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL (August 2010). "Low-dose doxepin: in the treatment of insomnia". CNS Drugs. 24 (8): 713–720. doi:10.2165/11200810-000000000-00000. PMID 20658801. S2CID 26739281.
Härtter S, Tybring G, Friedberg T, Weigmann H, Hiemke C (July 2002). "The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19". Pharmaceutical Research. 19 (7): 1034–1037. doi:10.1023/a:1016478708902. PMID 12180536. S2CID 8089917.

"Sinepin Capsules 25mg - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Marlborough Pharmaceuticals Ltd. 22 September 2011. Retrieved 3 December 2013.

Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, et al. (August 2005). "Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets". Pharmacogenetics and Genomics. 15 (8): 579–587. doi:10.1097/01.fpc.0000167331.30905.9e. PMID 16007002. S2CID 41765748.
Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL (August 2010). "Low-dose doxepin: in the treatment of insomnia". CNS Drugs. 24 (8): 713–720. doi:10.2165/11200810-000000000-00000. PMID 20658801. S2CID 26739281.
Härtter S, Tybring G, Friedberg T, Weigmann H, Hiemke C (July 2002). "The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19". Pharmaceutical Research. 19 (7): 1034–1037. doi:10.1023/a:1016478708902. PMID 12180536. S2CID 8089917.

Kirchheiner J, Henckel HB, Franke L, Meineke I, Tzvetkov M, Uebelhack R, et al. (August 2005). "Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets". Pharmacogenetics and Genomics. 15 (8): 579–587. doi:10.1097/01.fpc.0000167331.30905.9e. PMID 16007002. S2CID 41765748.
Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL (August 2010). "Low-dose doxepin: in the treatment of insomnia". CNS Drugs. 24 (8): 713–720. doi:10.2165/11200810-000000000-00000. PMID 20658801. S2CID 26739281.
Härtter S, Tybring G, Friedberg T, Weigmann H, Hiemke C (July 2002). "The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19". Pharmaceutical Research. 19 (7): 1034–1037. doi:10.1023/a:1016478708902. PMID 12180536. S2CID 8089917.